208 related articles for article (PubMed ID: 38431713)
1. Structural dynamics of RAF1-HSP90-CDC37 and HSP90 complexes reveal asymmetric client interactions and key structural elements.
Finci LI; Chakrabarti M; Gulten G; Finney J; Grose C; Fox T; Yang R; Nissley DV; McCormick F; Esposito D; Balius TE; Simanshu DK
Commun Biol; 2024 Mar; 7(1):260. PubMed ID: 38431713
[TBL] [Abstract][Full Text] [Related]
2. Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.
García-Alonso S; Mesa P; Ovejero LP; Aizpurua G; Lechuga CG; Zarzuela E; Santiveri CM; Sanclemente M; Muñoz J; Musteanu M; Campos-Olivas R; Martínez-Torrecuadrada J; Barbacid M; Montoya G
Mol Cell; 2022 Sep; 82(18):3438-3452.e8. PubMed ID: 36055235
[TBL] [Abstract][Full Text] [Related]
3. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
Czemeres J; Buse K; Verkhivker GM
PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
[TBL] [Abstract][Full Text] [Related]
4. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
Stetz G; Verkhivker GM
J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
[TBL] [Abstract][Full Text] [Related]
5. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
Roiniotis J; Masendycz P; Ho S; Scholz GM
Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
[TBL] [Abstract][Full Text] [Related]
6. Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase.
Verba KA; Wang RY; Arakawa A; Liu Y; Shirouzu M; Yokoyama S; Agard DA
Science; 2016 Jun; 352(6293):1542-7. PubMed ID: 27339980
[TBL] [Abstract][Full Text] [Related]
7. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
[TBL] [Abstract][Full Text] [Related]
8. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
[TBL] [Abstract][Full Text] [Related]
9. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 provides a platform for kinase dephosphorylation by PP5.
Jaime-Garza M; Nowotny CA; Coutandin D; Wang F; Tabios M; Agard DA
Nat Commun; 2023 Apr; 14(1):2197. PubMed ID: 37069154
[TBL] [Abstract][Full Text] [Related]
12. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
[TBL] [Abstract][Full Text] [Related]
13. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
Roe SM; Ali MM; Meyer P; Vaughan CK; Panaretou B; Piper PW; Prodromou C; Pearl LH
Cell; 2004 Jan; 116(1):87-98. PubMed ID: 14718169
[TBL] [Abstract][Full Text] [Related]
14. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
[TBL] [Abstract][Full Text] [Related]
15. HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation.
Oberoi J; Guiu XA; Outwin EA; Schellenberger P; Roumeliotis TI; Choudhary JS; Pearl LH
Nat Commun; 2022 Nov; 13(1):7343. PubMed ID: 36446791
[TBL] [Abstract][Full Text] [Related]
16. A client-binding site of Cdc37.
Terasawa K; Minami Y
FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
[TBL] [Abstract][Full Text] [Related]
17. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
[TBL] [Abstract][Full Text] [Related]
18. Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4.
Zhao Q; Boschelli F; Caplan AJ; Arndt KT
J Biol Chem; 2004 Mar; 279(13):12560-4. PubMed ID: 14701845
[TBL] [Abstract][Full Text] [Related]
19. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
Prince T; Sun L; Matts RL
Biochemistry; 2005 Nov; 44(46):15287-95. PubMed ID: 16285732
[TBL] [Abstract][Full Text] [Related]
20. Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant.
Bjorklund DM; Morgan RML; Oberoi J; Day KLIM; Galliou PA; Prodromou C
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
